Tint G S, Pentchev P, Xu G, Batta A K, Shefer S, Salen G, Honda A
Department of Veterans Affairs New Jersey Health Care System, East Orange, New Jersey 07018, USA.
J Inherit Metab Dis. 1998 Dec;21(8):853-63. doi: 10.1023/a:1005474803278.
Niemann-Pick disease type C (NP-C) is a rare genetic disorder characterized by progressive neurodegeneration, frequent developmental delay and early death. Tissues of affected individuals accumulate large quantities of free cholesterol in lysosomes. Because cytotoxic oxygenated derivatives of cholesterol are known to form readily when cholesterol concentrations are elevated, we searched for these compounds in liver, kidney, spleen and brain from mice with the NP-C phenotype. In order of abundance, we identified 7 alpha- and 7 beta-hydroxycholesterol, 5 alpha, 6 alpha-epoxycholestan-3 beta-ol, 4 beta-hydroxycholesterol, cholest-4-en-3 beta, 7 alpha-diol and cholest-4-en-3 beta, 6 beta-diol in most tissue samples. Cholesterol concentrations in affected mice were increased 3-fold in kidney and 7- to 8-fold in spleen and liver compared to controls (all p < 0.001) but were unchanged in brain. Although oxysterol levels were markedly elevated in nonbrain tissue, the oxysterol and cholesterol concentrations increased proportionally so that oxysterols expressed as percentage of total sterols were the same for all animals (0.34 +/- 0.19% averaged over all organs in affected animals vs 0.40 +/- 0.42% in control mice). In contrast to peripheral tissue, we could not detect any increase in either absolute or relative oxysterol levels in the brains of affected and control mice (49 +/- 61 vs 53 +/- 43 micrograms/g wet weight and 0.45 +/- 0.52 vs 0.47 +/- 0.37%, respectively). Thus, brain sterols are normal in NP-C mice and it is unlikely that an accumulation of cytotoxic oxygenated derivatives of cholesterol could account for the progressive neuropathology seen in the disease.
尼曼-皮克C型病(NP-C)是一种罕见的遗传性疾病,其特征为进行性神经退行性变、频繁的发育迟缓及早期死亡。患病个体的组织在溶酶体中积累大量游离胆固醇。由于已知当胆固醇浓度升高时,胆固醇的细胞毒性氧化衍生物很容易形成,因此我们在具有NP-C表型的小鼠的肝脏、肾脏、脾脏和大脑中寻找这些化合物。按照丰度顺序,我们在大多数组织样本中鉴定出7α-和7β-羟基胆固醇、5α,6α-环氧胆甾烷-3β-醇、4β-羟基胆固醇、胆甾-4-烯-3β,7α-二醇和胆甾-4-烯-3β,6β-二醇。与对照组相比,患病小鼠肾脏中的胆固醇浓度增加了3倍,脾脏和肝脏中的胆固醇浓度增加了7至8倍(所有p<0.001),但大脑中的胆固醇浓度没有变化。尽管非脑组织中的氧化甾醇水平明显升高,但氧化甾醇和胆固醇浓度成比例增加,因此所有动物中氧化甾醇占总甾醇的百分比相同(患病动物所有器官的平均值为0.34±0.19%,对照小鼠为0.40±0.42%)。与外周组织相反,我们在患病和对照小鼠的大脑中均未检测到氧化甾醇的绝对水平或相对水平有任何增加(分别为49±61与53±43微克/克湿重,以及0.45±0.52与0.47±0.37%)。因此,NP-C小鼠的脑甾醇是正常的,胆固醇的细胞毒性氧化衍生物的积累不太可能解释该疾病中所见的进行性神经病理学。